Actively Recruiting
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Led by Lahey Clinic · Updated on 2025-12-08
500
Participants Needed
1
Research Sites
1365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
CONDITIONS
Official Title
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled to have a nephroureterectomy, cystectomy, or cystoscopy for newly diagnosed or recurrent bladder cancer
- Control group with no known evidence of bladder cancer providing one urine sample
- Age greater than 18 years
You will not qualify if you...
- Age less than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lahey Clinic, Inc.
Burlington, Massachusetts, United States, 01805
Actively Recruiting
Research Team
K
Kimberly Rieger-Christ, PhD
CONTACT
L
Linda M. Topjian
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here